Final Program in it's entirety - MyGirlsBlood
Final Program in it's entirety - MyGirlsBlood
Final Program in it's entirety - MyGirlsBlood
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Posters, Tuesday and Wednesday<br />
Index of Poster Presenters cont’d<br />
31P22<br />
Quality of Life <strong>in</strong> Patients with Congenital Hemophilia and<br />
Inhibitors <strong>in</strong> Japan<br />
Taki M1 , Tatsunami S2 , Shirahata A2 , Mimaya J2 , Takedani H2 ,<br />
Mak<strong>in</strong>o K2 , Ohira K2 , Kojima K2 , Wada I2 , Yoshikawa K2 1Department of Pediatrics, St. Marianna University School<br />
of Medic<strong>in</strong>e Yokohama City Seibu Hospital, Kanagawa,<br />
Japan, and 2The Research Committee on QOL Study<br />
Regard<strong>in</strong>g Coagulation Disorders <strong>in</strong> Japan, Kanagawa, Japan<br />
31P23<br />
Quality of Life <strong>in</strong> Parents of Children with Hemophilia - Results<br />
of the ESCHQoL Study<br />
Tedgard U1 , Ljung R1 , Bull<strong>in</strong>ger M2 , von Mackensen S2 1Dept of Paediatrics, University Hospital, Malmo, Sweden,<br />
2Institute of Medical Psychology, University Medical Centre<br />
Hamburg-Eppendorf, Germany<br />
31P24<br />
Blood Coagulation Factor VIII Activity Simulation Software for<br />
Optimal Dosage and Adm<strong>in</strong>istration - for the Better Quality<br />
of Life<br />
Tomotsugu A, Yamauchi K<br />
Bayer Japan, Osaka, Japan<br />
31P25<br />
Quality of Life Related to Health <strong>in</strong> Children Affected with<br />
Hemophilia Under the Age of 15 by Community Valencia<br />
(Spa<strong>in</strong>)<br />
Vañó L1 , Laguna S1 , Varela JA1 , Vila E1 , Ramón JA1 , Daras V1 ,<br />
Espada L1 , Usach J1 , Perez S2 , Querol F2 , Aznar JA2 1 2 Asociación de Hemofilia de la Comunidad, and Unidad de<br />
Hemostasia y Trombosis del Hospital La Fe de Valencia, Spa<strong>in</strong><br />
31P26<br />
Choices for a Better Future: The Lessons Learnt from an<br />
Educational Project<br />
Villaca PR1 , Okazaki E1 , Amaral JA2 , Sandoval E1 , Santos V1 ,<br />
D’Amico E1 1Hospital Das Cl<strong>in</strong>icas - Universidade de Sao Paulo and<br />
Fundação Verzol<strong>in</strong>i Escola Politecnica - University of São<br />
Paulo, Brazil<br />
31P27<br />
Assessment of Health-Related Quality of Life <strong>in</strong> VWD Patients<br />
– Results of the VWD-QoL Pilot-Study<br />
Von Mackensen S<br />
University of Hamburg, Germany<br />
31P28<br />
Longitud<strong>in</strong>al Assessment of Health Related Quality of Life<br />
<strong>in</strong> Young Hemophilia Patients <strong>in</strong> Europe<br />
Von Mackensen S<br />
University of Hamburg, Germany<br />
86<br />
31P29<br />
Content Validity of the Paediatric Hemophilia Quality of Life<br />
Assessment Tool <strong>in</strong> Ch<strong>in</strong>a<br />
Wu R1 , Young NL2 , Zhang J1 , Luke KH3 , Hang M4 , Blanchette<br />
V4 , Sun J5 , Li X6 , Poon MC7 1 2 Beij<strong>in</strong>g Children’s Hospital, Beij<strong>in</strong>g, Ch<strong>in</strong>a, Laurentian<br />
University, Sudbury, ON, Canada, 3Children’s Hospital of<br />
Eastern Ontario, Ottawa, ON, Canada, 4Hospital for Sick<br />
Children, Toronto, ON, Canada, 5Nanfang Hospital, Nanfang,<br />
Ch<strong>in</strong>a, 6Chengdu Children’s Hospital, Chengdu, Ch<strong>in</strong>a,<br />
7University of Calgary Foothills Medical Centre, Calgary, AB,<br />
Canada<br />
RARE CLOTTING FACTOR DEFICIENCIES<br />
32P04<br />
S<strong>in</strong>gle Center Experience on Rare Inherited Clott<strong>in</strong>g Factor<br />
Deficiency<br />
Madkhali I, Owaidah T and Al-Zahrani H<br />
K<strong>in</strong>g Faisal Specialist Hospital and RC, Riyadh, Saudi Arabia<br />
32P05<br />
The Factor XIII Database: A Look <strong>in</strong>to the Mutational<br />
Spectrum of F13 A and B Genes<br />
Biswas A, Ivaskevicius V, Oldenburg J, Thomas A<br />
Institute of Experimental Hematology and Transfusion<br />
Medic<strong>in</strong>e, Bonn, Germany<br />
32P06<br />
Cl<strong>in</strong>ical Manifestations of Lebanese Population with<br />
Afibr<strong>in</strong>ogenemia<br />
Djambas Khayat C1, 2 , Bakhos- Asmar J1 , Germanos M2 ,<br />
Samaha H1 , Khayat G2 , Sakr S1 1Lebanese Association for Hemophilia, Beirut, Lebanon,<br />
2Hotel Dieu de France Hospital, Angers, France<br />
32P07<br />
Congenital Dysfibr<strong>in</strong>ogenemia: Association between Cl<strong>in</strong>ical<br />
Symptoms, Laboratory Parameters, and Genetic Mutations<br />
Flommersfeld S, Fischer R, Kemkes-Matthes B, Heid<strong>in</strong>ger K<br />
University Center of Transfusion Medic<strong>in</strong>e and Haemostasis,<br />
Giessen and Marburg, Germany<br />
32P08<br />
A Novel Nonsense Mutation Identified <strong>in</strong> a Congenital<br />
Afibr<strong>in</strong>ogenemia Patient (FGB exon 7: GLU 369X) from<br />
Tenerife, Canary Islands, Spa<strong>in</strong><br />
García Talavera J1 , Neerman-Arbez M2 , Marrero C1 , León<br />
A1 , de Agust<strong>in</strong> T3 1Hospital Universitario Ntra Sra de Candelaria, Tenerife,<br />
Canary Islands, Spa<strong>in</strong>,<br />
2Geneva University Medical Centre, Switzerland, Geneva,<br />
Switzerland, 3CSL Behr<strong>in</strong>g, Marburg, Germany